About
Basic Data Updated:
1 month agoVani Pharma Labs Limited, previously known as Vani Chemical & Intermediates Ltd, has been involved in the production of APIs and bulk drugs. The manufacturing of these essential products is the core of the company's operations. The range of APIs includes dipyrone/analgin, isopropylantipyrine/propyphenazone, phenazone salicylate, antipyrine/phenazone, atenolol, metoprolol tartrate, and mefenamic acid. Additionally, the bulk drugs produced by VPLL consist of phenyl hydrazine freebase, acetyl phenyl hydrazine, and 4 - hydroxy carbazole (Intermediate for Carvedilol). The company's plant, situated in Phase I of Jeedimetla Industrial Development Area, Hyderabad, spans over 2 acres of land.
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
| CIN/LLPIN/FCRN | U24110TG1976PLC002040 |
| Company No. | 002040 |
| Company Classification | Public Limited Indian Non-Government Company |
| Incorporation Date | 15 Jun 1976 |
| Date of AGM | 31 Dec 2020 |
| Date of Balance Sheet | 31 Mar 2020 |
| Listing Status | Unlisted |
| ROC Code | Roc Hyderabad |
Products or Services related to Vani Pharma Labs Limited
Antipyretic and Analgesic API
Bisoprolol Fumarate Tablet
Financials of Vani Pharma Labs Limited
Vani Pharma Labs Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 69.39% increase. The company also saw a substantial improvement in profitability, with a 56.27% increase in profit. The company's net worth Soared by an impressive increase of 95.15%.
Corporate Structure
Unlock access to Vani Pharma Labs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Vani Pharma Labs Limited
Unlock and access historical data on people associated with Vani Pharma Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (1)
CM
Chakradhar Mallampati
Managing DirectorAppointment Date: 22-Dec-1998
Status: Current
Board Members(2)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Standard Chartered Bank Creation Date: 09 Jun 2022 | ₹5.00 Cr | Open |
Axis Bank Limited Creation Date: 11 May 2022 | ₹7.50 Cr | Open |
Others Creation Date: 12 Nov 2020 | ₹2.52 Cr | Open |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vani Pharma Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vani Pharma Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Vani Organics Private Limited
Active
39 years 8 months Kalyan Gadde and Chakradhar Mallampati are mutual person
Recent activity within the organization
Charges
A charge with Standard Chartered Bank amounted to Rs. 5.00 cr with Charge ID 100581050 was registered on 09 Jun 2022.
09 Jun 2022Charges
A charge with Axis Bank Limited amounted to Rs. 7.50 cr with Charge ID 100579224 was registered on 11 May 2022.
11 May 2022Director Appointment
Lakshmi Kranthi Mallampati was appointed as a Additional Director was appointed as a Additional Director on 24 Dec 2021 & has been associated with this company since 2 years 5 months .
24 Dec 2021Charges
A charge with Others of Rs. 19.26 cr registered on 26 Jun 2020 with Charge ID 100358673 was modified on 29 Apr 2021.
29 Apr 2021Annual General Meeting
Vani Pharma Labs Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records.
31 Dec 2020
Frequently asked questions
What is the Incorporation or founding date of Vani Pharma Labs Limited?
